QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
QL01FX Other monoclonal antibodies and antibody drug conjugates
QL01FX01 edrecolomab
QL01FX02 gemtuzumab ozogamicin
QL01FX03 catumaxomab
QL01FX04 ipilimumab
QL01FX05 brentuximab vedotin
QL01FX06 dinutuximab beta
QL01FX07 blinatumomab
QL01FX08 elotuzumab
QL01FX09 mogamulizumab
QL01FX10 olaratumab
QL01FX11 bermekimab
QL01FX12 tafasitamab
QL01FX13 enfortumab vedotin
QL01FX14 polatuzumab vedotin
QL01FX15 belantamab mafodotin
QL01FX16 oportuzumab monatox
QL01FX17 sacituzumab govitecan
QL01FX18 amivantamab
QL01FX19 sabatolimab
QL01FX20 tremelimumab
QL01FX21 naxitamab
QL01FX22 loncastuximab tesirine
QL01FX23 tisotumab vedotin
QL01FX24 teclistamab
QL01FX25 mosunetuzumab
QL01FX26 mirvetuximab soravtansine
QL01FX27 epcoritamab
QL01FX28 glofitamab
QL01FX29 talquetamab
Last updated: 2024-01-17